Cancer: Why Most People Are Not To Blame

Kalmost 500,000 people develop cancer in Germany every year, and every second person dies from it, despite improved therapies. Cancer researcher Mathias Heikenwälder is professor and department head at the German Cancer Research Center in Heidelberg. He explains how cancer develops and why promising therapeutic approaches often fail in practice.

WELT: One of the great hopes in cancer treatment is immunotherapy, in which the body’s immune system is activated to kill cancer cells. Why doesn’t it help with liver cancer?

Mathias Heikenwälder: Immunotherapy is a new weapon in the cancer arsenal,

.